Germline genetic testing in prostate cancer – further enrichment in variant histologies?

por Markowski, Mark C., Antonarakis, Emmanuel S.
Publicado 2018

Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer

por Markowski, Mark C, Pienta, Kenneth J
Publicado 2015

Bipolar androgen therapy (BAT): A patient's guide

por Denmeade, Samuel, Antonarakis, Emmanuel S, Markowski, Mark C
Publicado 2022

Advanced renal cell carcinoma and COVID-19 — a personal perspective

por Ged, Yasser, Markowski, Mark C., Pierorazio, Phillip M.
Publicado 2020

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer

por Denmeade, Samuel R, Sena, Laura A, Wang, Hao, Antonarakis, Emmanuel S, Markowski, Mark C
Publicado 2023

ORCHID: A phase II study of Olaparib in Metastatic Renal Cell Carcinoma Patients HarborIng a BAP1 or Other DNA Repair Gene Mutations

por Ged, Georges, Rifkind, Irina, Tony, Lori, Daugherty, Keegan, Michalik, Amber, Wang, Hao, Carducci, Michael, Markowski, Mark
Publicado 2023

Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss

por Markowski, Mark C., Wang, Hao, De Marzo, Angelo M., Schweizer, Michael T., Antonarakis, Emmanuel S., Denmeade, Samuel R.
Publicado 2022

CLRM-09 MAPPING THE DISTRIBUTION AND CLINICAL ASSOCIATIONS OF BRAIN METASTASES IN RENAL CELL CARCINOMA

por Kamson, David Olayinka, Feinaj, Ardit, Markowski, Mark, Yerrapragada, Anirudh, Elias, Roy, Shenderov, Eugene, Bettegowda, Chetan, Singla, Nirmish, Ged, Yasser
Publicado 2023

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies

por Sfanos, Karen S., Markowski, Mark C., Peiffer, Lauren B., Ernst, Sarah E., White, James R., Pienta, Kenneth J., Antonarakis, Emmanuel S., Ross, Ashley E.
Publicado 2018

Early Treatment with Fumagillin, an Inhibitor of Methionine Aminopeptidase-2, Prevents Pulmonary Hypertension in Monocrotaline-Injured Rats

por Kass, Daniel J., Rattigan, Eileen, Kahloon, Rehan, Loh, Katrina, Yu, Liyang, Savir, Asaf, Markowski, Mark, Saqi, Anjali, Rajkumar, Revathi, Ahmad, Ferhaan, Champion, Hunter C.
Publicado 2012

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience

por Deek, Matthew P., Yu, Colburn, Phillips, Ryan, Song, Daniel Y., Deville, Curtiland, Greco, Stephen, DeWeese, Theodore L., Antonarakis, Emmanuel S., Markowski, Mark, Paller, Channing, Denmeade, Samuel, Carducci, Michael, Walsh, Patrick C., Pienta, Kenneth J., Eisenberger, Mario, Tran, Phuoc T.
Publicado 2019

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression

por Chen, Jiayu, Zheng, Qizhi, Hicks, Jessica L., Trabzonlu, Levent, Ozbek, Busra, Jones, Tracy, Vaghasia, Ajay, Larman, Tatianna C., Wang, Rulin, Markowski, Mark C., Denmeade, Sam R., Pienta, Kenneth J., Hruban, Ralph H., Antonarakis, Emmanuel S., Gupta, Anuj, Dang, Chi V, Yegnasubramanian, Srinivasan, De Marzo, Angelo M.
Publicado 2023

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

por Deek, Matthew P., Van der Eecken, Kim, Phillips, Ryan, Parikh, Neil R., Velho, Pedro Isaacsson, Lotan, Tamara L., Kishan, Amar U., Maurer, Tobias, Boutros, Paul C., Hovens, Christopher, Abramowtiz, Matthew, Pollack, Alan, Desai, Neil, Stish, Bradley, Feng, Felix Y., Eisenberger, Mario, Carducci, Michael, Pienta, Kenneth J., Markowski, Mark, Paller, Channing J., Antonarakis, Emmanuel S., Berlin, Alejandro, Ost, Piet, Tran, Phuoc T.
Publicado 2021

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with (18)F-DCFPyL

por Werner, Rudolf A., Habacha, Bilêl, Lütje, Susanne, Bundschuh, Lena, Higuchi, Takahiro, Hartrampf, Philipp, Serfling, Sebastian E., Derlin, Thorsten, Lapa, Constantin, Buck, Andreas K., Essler, Markus, Pienta, Kenneth J., Eisenberger, Mario A., Markowski, Mark C., Shinehouse, Laura, AbdAllah, Rehab, Salavati, Ali, Lodge, Martin A., Pomper, Martin G., Gorin, Michael A., Bundschuh, Ralph A., Rowe, Steven P.
Publicado 2022

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer afte...

por Kapoor, Roche, Deek, Matthew P., McIntyre, Riley, Raman, Natasha, Kummerlowe, Megan, Chen, Iyah, Gaver, Matt, Wang, Hao, Denmeade, Sam, Lotan, Tamara, Paller, Channing, Markowski, Mark, Carducci, Michael, Eisenberger, Mario, Beer, Tomasz M., Song, Daniel Y., DeWeese, Theodore L., Hearn, Jason W., Greco, Stephen, DeVille, Curtiland, Desai, Neil B., Heath, Elisabeth I., Liauw, Stanley, Spratt, Daniel E., Hung, Arthur Y., Antonarakis, Emmanuel S., Tran, Phuoc T.
Publicado 2019

Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors

por Piha-Paul, Sarina A, Hann, Christine L, French, Christopher A, Cousin, Sophie, Braña, Irene, Cassier, Phillippe A, Moreno, Victor, de Bono, Johann S, Harward, Sara Duckworth, Ferron-Brady, Geraldine, Barbash, Olena, Wyce, Anastasia, Wu, Yuehui, Horner, Thierry, Annan, Meg, Parr, Nigel J, Prinjha, Rabinder K, Carpenter, Christopher L, Hilton, John, Hong, David S, Haas, Naomi B, Markowski, Mark C, Dhar, Arindam, O’Dwyer, Peter J, Shapiro, Geoffrey I
Publicado 2019

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC

por Sena, Laura A., Kumar, Rajendra, Sanin, David E., Thompson, Elizabeth A., Rosen, D. Marc, Dalrymple, Susan L., Antony, Lizamma, Yang, Yuhan, Gomes-Alexandre, Carolina, Hicks, Jessica L., Jones, Tracy, Bowers, Kiara A., Eskra, Jillian N., Meyers, Jennifer, Gupta, Anuj, Skaist, Alyza, Yegnasubramanian, Srinivasan, Luo, Jun, Brennen, W. Nathaniel, Kachhap, Sushant K., Antonarakis, Emmanuel S., De Marzo, Angelo M., Isaacs, John T., Markowski, Mark C., Denmeade, Samuel R.
Publicado 2022

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

por Hasan, Hamza, Deek, Matthew P., Phillips, Ryan, Hobbs, Robert F., Malek, Reem, Radwan, Noura, Kiess, Ana P., Dipasquale, Shirl, Huang, James, Caldwell, Terry, Leitzel, Jessica, Wendler, Danielle, Wang, Hao, Thompson, Elizabeth, Powell, Jonathan, Dudley, Sara, Deville, Curtiland, Greco, Stephen C., Song, Daniel Y., DeWeese, Theodore L., Gorin, Michael A., Rowe, Steven P., Denmeade, Sam, Markowski, Mark, Antonarakis, Emmanuel S., Carducci, Michael A., Eisenberger, Mario A., Pomper, Martin G., Pienta, Kenneth J., Paller, Channing J., Tran, Phuoc T.
Publicado 2020